EXPERT, EXPosurE Registry RiociguaT in patients with pulmonary hypertension

Study Objective:

The objective is the assessment of the long-term safety profile of Adempas® in real life clinical practice.

Participation conditions

Inclusion criteria

1. Female and male patients who start or are on treatment with Adempas®
2. Written informed consent

Exclusion criteria

1. Patients currently participating in an interventional clinical trial
 

Participating centers:

Centre Hospitalier de Luxembourg (CHL)